Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder

Background: Only less than 40% of patients with Major depressive disorder (MDD) can achieve remission after several weeks of initial antidepressant treatment. Predicting whether the prescribed treatment is effective in the following course may help clinicians modify the treatment regimen in time, and reduce the staggering burden for patients and society. However, there are not yet reliable markers based on neurobiological change after a treatment regimen steadily applied, for predicting clinical treatment outcome. The striatal circuits often exhibit abnormality for MDD patients, and are implicated in antidepressant treatments. Methods: Nineteen first-episode drug-naive MDD patients (nine females, mean age was 30 years old) were recruited to undergo clinical symptom assessment and resting state fMRI scanning at baseline, after 2 and 8 weeks of treatment with duloxetine. A seed-based analysis was used to obtain functional connectivity (FC) maps of six sub-regions of the stratum, then we explored the relationship of 2-week changes of striatal FC with clinical symptom improvement after 8-week duloxetine treatment. Results: The results revealed that 2-week FC changes of the striatal cognitive and affective subdivisions with the frontoparietal regions positively correlated with 8-week symptom improvement. We also found that early FC changes between the striatal motor subdivision and the motor-related cortical regions negatively correlated with later symptom improvement. Conclusions: These findings suggest that change of the FC of the cortical-striatal circuits at the early stage of treatment is critical for later remission of MDD. Furthermore, the association between the FC change and symptom improvement may have significant implication for clinical practice to regard neural changes as reference for evaluating how antidepressant treatment works

Antidepressant · Anxiety · Cognition · Duloxetine · Major depressive disorder · Pathology · Psychiatry · Regimen · Functional Brain Connectivity Studies · Medicine · Mental Health Research Topics · Psychology · Treatment of Major Depression · Internal Medicine

• Cognition and Depression

  Ian H Gotlib, Jutta Joormann•Annual Review of Clinical…•2010

  Incluir item

• Dopamine, learning and motivation

  Open Access•Richard A Wise, ROY A WISE•Nature Reviews Neuroscience•2004

  Incluir item

• Large-Scale Network Dysfunction in Major Depressive Disorder

  Roselinde H Kaiser, Jessica R Andrews-Hanna et al.•JAMA Psychiatry•2015

  Incluir item

• Dpabi

  Open Access•Chao-Gan Yan, Chao‐Gan Yan et al.•Neuroinformatics•2016

  Incluir item

• The debate over dopamine’s role in reward

  Open Access•Kent C Berridge•Psychopharmacology•2007

  Incluir item

• The organization of the human cerebral cortex estimated by intrinsic functional connectivity

  B T Thomas Yeo, Fenna M Krienen et al.•Journal of Neurophysiology•2011

  Incluir item

• Development of a Rating Scale for Primary Depressive Illness

  Open Access•MAX HAMILTON•British Journal of Social and…•1967

  Incluir item

• Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion

  Open Access•Jonathan D Power, Kelly A Barnes et al.•NeuroImage•2012

  Incluir item

• Functional and Structural Alterations in the Cingulate Motor Area Relate to Decreased Fronto-Striatal Coupling in Major Depressive Disorder with Psychomotor Disturbances

  Open Access•Benny Liberg, Paul Klauser et al.•Frontiers in Psychiatry•2014

  Incluir item

• Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function

  Hannah R Snyder•Psychological Bulletin•2013

  Incluir item